School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Intercure Ltd. INCR

Healthcare · Drug Manufacturers - Specialty & Generic

$5.17last close 2026-10-09 · market cap $77.57M · delayed data

Trailing returns

1M-1.52%
3M+5.51%
6M+36.05%
1Y-38.45%
5Y-84.61%

Basis: Adjusted daily closes.

What it does

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Open INCR in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies